7
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36316 |
mTOR inhibitor-8
mTOR-IN-8 |
mTOR; Autophagy | Autophagy; PI3K/Akt/mTOR signaling |
mTOR inhibitor-8 是一种有效的 mTOR 抑制剂和自噬诱导剂,具有抗病毒和抗肿瘤活性。mTOR inhibitor-8 抑制A549细胞的生长,可用于研究非小细胞肺癌。 | |||
T1958 |
AZ20
|
ATM/ATR; mTOR | DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
AZ20 是一种有效且特异性的 ATR 激酶抑制剂,IC50值为 5 nM。它还抑制mTOR 活性,IC50值为 38 nM。 | |||
T19661 |
8-Chloroadenosine
NSC 354258,8-Cl-Ado,NSC354258,NSC-354258,8-氯腺嘌呤核苷 |
AMPK | Chromatin/Epigenetic; PI3K/Akt/mTOR signaling |
8-Chloroadenosine (NSC-354258) 是一种 5' AMP 激活的蛋白激酶激动剂,可能用于治疗慢性淋巴细胞白血病。 它的活性与 mTOR 通路的抑制有关。它是一种核苷类似物。在体内代谢为 8-氯-ATP。在转录过程中掺入 RNA 并抑制 RNA 合成。在 MM.1S、RPMI-8226 和 U266 癌细胞系中表现出细胞毒性;在 A549 和 H1299 细胞中诱导 G2/M 细胞周期停滞和有丝分裂灾难。它已被证明可消耗 ATP 并抑制血液恶性肿瘤以及肺癌和乳腺癌细胞系中的肿瘤生长。 | |||
T63470 |
PI3K/mTOR Inhibitor-8
|
||
PI3K/mTOR Inhibitor-8 是 PI3K (PI3Kα IC50: 0.46 nM) 和 mTOR (mTOR IC50: 12 nM) 双重抑制剂。PI3K/mTOR Inhibitor-8 能够将 HCT-116 细胞的细胞周期阻滞在G1/S 期,并诱导其凋亡 (apoptosis)。 | |||
T62580 |
PI3K-IN-37
|
||
PI3K-IN-37 (Example 84.1) 是一种 PI3K α (IC50: 6 nM) /β (IC50: 8 nM) /δ (IC50: 4 nM) 抑制剂。PI3K-IN-37 对 mTOR 具有抑制作用,其 IC50 值为4 nM。 | |||
T36084 |
PKI-179
|
||
PKI-179 is a potent and orally active dual PI3K/mTOR inhibitor, with IC50s of 8 nM, 24 nM, 74 nM, 77 nM, and 0.42 nM for PI3K-α, PI3K-β, PI3K-γ, PI3K-δ and mTOR, respectively. PKI-179 also exhibits activity over E545K and H1047R, with IC50s of 14 nM and 11 nM, respectively. PKI-179 shows anti-tumor activity in vivo[1][2]. PKI-179 inhibits the cell proliferation, with IC50s of 22 nM and 29 nM for MDA361 and PC3 cells, respectively[1].PKI-179 shows inhibitory activity against a panel of 361 other ... | |||
T36085 | PKI-179 hydrochloride | ||
PKI-179 is an orally bioavailable dual inhibitor of PI3K and mammalian target of rapamycin (mTOR). In an in vitro enzymatic assay, it potently inhibits PI3K (IC50s = 8, 24, 17, and 74 nM for isoforms α, β, δ, and γ, respectively), two common PI3Kα mutants, E545K and H1047R (IC50s = 14 and 11 nM, respectively), and mTOR (IC50 = 0.42 nM). PKI-179 is selective for PI3K and mTOR over a panel of 361 other kinases at IC50 values up to 50 μM, hERG (IC50 > 30 μM), and cytochrome P450 (CYP) isoforms (IC5... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T40483 |
8-Aminoadenosine
8-NH2-Ado,8-氨基腺苷 |
||
8-Aminoadenosine (8-NH2-Ado) is an RNA-directed nucleoside analogue that effectively diminishes cellular ATP levels and impedes mRNA synthesis. Furthermore, it effectively obstructs Akt/mTOR signaling, inducing autophagy and apoptosis in a p53-independent manner. Its significant antitumor activity further highlights its therapeutic potential. |